News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2022 Caitlin E. Cox December 01, 2022
News Conference News PCR London Valves 2022 Registry Results See Less PVL, Pacemakers With Acurate neo2 Shelley Wood November 29, 2022
News Daily News LivaNova Recalls Some LifeSPARC Controllers Used in Advanced Circulatory Support L.A. McKeown September 30, 2022
News Conference News TCT 2022 Sizing Mismatch a Problem for Balloon-Expandable Valves in Small Annuli TAVI Yael L. Maxwell September 18, 2022
News Conference News TCT 2022 Both Surgical, Percutaneous Closure Boost Survival in Post-STEMI VSD Shelley Wood September 18, 2022
News Conference News TCT 2022 FLASH: More Data to Support Mechanical Thrombectomy in PE L.A. McKeown September 18, 2022
News Conference News TCT 2022 TEER Linked to Better 1-Year Survival in Shock Patients With Significant MR Yael L. Maxwell September 17, 2022
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Daily News Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression Michael O'Riordan August 08, 2022
News Daily News US Dobutamine Shortage a ‘Huge Problem’—What’s the Solution? Shelley Wood July 15, 2022
News Daily News Subclinical Thrombosis After TAVI Benign, at Least to 3 Years Michael O'Riordan June 07, 2022
News Daily News ‘Right Time, Right Moment’: Same-Day Discharge After TAVI Safe, Feasible Michael O'Riordan March 21, 2022
News Conference News Longer-Term LRT Results ‘Encouraging’ for TAVI in Low-risk Patients Todd Neale March 01, 2022
News Conference News STS 2022 Tricuspid Repair During Mitral Valve Surgery Prevents TR Progression Michael O'Riordan February 04, 2022
News Conference News THT 2022 PA Pressure Monitoring Useful Even in Presymptomatic CHF Patients L.A. McKeown February 03, 2022
News Conference News THT 2022 LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety Caitlin E. Cox February 02, 2022
News Daily News In the US, HF Prevalence—and Costs—Rising Steeply: HFSA Report Michael O'Riordan January 27, 2022